Minerva Neurosciences, Inc

NERVNASDAQUSD
5.43 USD
0.43 (8.60%)🟢PRE MARKET (AS OF 07:31 PM EDT)
🟢Market: OPEN

NERV is currently priced at $5.43. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (185.3%) and a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Aug 26, 2026.

Open?$5.01
High?$5.63
Low?$4.94
Prev. Close?$5.00
Volume?367.8K
Avg. Volume?225.5K
VWAP?$5.36
Rel. Volume?1.63x
Bid / Ask
Bid?$4.51 × 100
Ask?$6.33 × 100
Spread?$1.82
Midpoint?$5.42
Valuation & Ratios
Market Cap?259.3M
Shares Out?47.7M
Float?39.1M
Float %?84.0%
P/E Ratio?N/A
P/B Ratio?-1.22
EPS?-$8.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
Employees
7
Market Cap
238.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2014-07-01
Address
1500 DISTRICT AVENUE
BURLINGTON, MA 01803
Phone: 617-600-7373
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
66
Piotroski F-Score?0/9Weak
Altman Z-Score?-11.47Distress
Confidence?53%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?4.49%Low
Short Interest?1.8M
Days to Cover?11.8
Free Float39.1M
Avg Daily Volume149.4K
Settlement Date2026-08-14
Financial Health
Current Ratio?20.14Strong
Quick Ratio?20.14Strong
Cash Ratio?6.23Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
S&P
97
-1.22CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-6.7CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
Peers
50
S&P
97
185.3%STRONG
ROA?
S&P
3
-415.6%WEAK
Cash Flow & Enterprise
FCF?$-26168723
Enterprise Value?$234.6M
Fundamentals ratios updated end of day